Title:
LIPOSOME COMPOSITION AND LIPOSOME-CONTAINING PHARMACEUTICAL COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2023/190709
Kind Code:
A1
Abstract:
A liposome composition which comprises (A) liposomes containing dihydrosphingomyelin and a diacylglycerol-polyethylene glycol, (B) a drug and (C) a sulfate and/or sucrose octasulfate, and in which (A) encapsulates (B), wherein: the diacylglycerol-polyethylene glycol is distearoylglycerol-polyethylene glycol; and (B) is 4-(3-chloro-4-(ethylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide represented by formula (I) or pharmaceutically acceptable salt thereof.
More Like This:
Inventors:
MATSUMOTO YASUNOBU (JP)
HYODO KENJI (JP)
TAKASE YASUTAKA (JP)
KATSURADA YURI (JP)
ANDO YUICHIRO (JP)
ONIZAWA YUJI (JP)
SUZUKI TAKUYA (JP)
HYODO KENJI (JP)
TAKASE YASUTAKA (JP)
KATSURADA YURI (JP)
ANDO YUICHIRO (JP)
ONIZAWA YUJI (JP)
SUZUKI TAKUYA (JP)
Application Number:
PCT/JP2023/012862
Publication Date:
October 05, 2023
Filing Date:
March 29, 2023
Export Citation:
Assignee:
EISAI R&D MAN CO LTD (JP)
International Classes:
A61K9/127; A61K31/47; A61K47/02; A61K47/12; A61K47/14; A61K47/24; A61K47/26; A61K47/28; A61P35/00; C07D215/48
Domestic Patent References:
WO2012144463A1 | 2012-10-26 | |||
WO2006030941A1 | 2006-03-23 | |||
WO2021226368A1 | 2021-11-11 | |||
WO2018181963A1 | 2018-10-04 |
Foreign References:
CN112603890A | 2021-04-06 |
Attorney, Agent or Firm:
HASEGAWA Yoshiki et al. (JP)
Download PDF: